Primary Biliary Cholangitis Clinical Trials

A listing of Primary Biliary Cholangitis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 44 clinical trials
Featured trial
Primary Biliary Cholangitis (PBC) Assure

People with Primary Biliary Cholangitis (PBC) are asked to participate in a research study being conducted by North Shore University Hospital. 

  • 0 views
  • 03 Aug, 2021
  • 1 location
Featured trial
TARGET-PBC: A 5-year longitudinal observational study of patients with primary biliary cholangitis

TARGET-PBC: A 5-year longitudinal observational study of patients with primary biliary cholangitis

  • 129 views
  • 23 Nov, 2020
  • 1 location
Featured trial
A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis

A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis

  • 90 views
  • 25 Mar, 2021
  • 1 location
Featured trial
A Randomized, Double-blind, Multi-dose, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of GSK2330672 Administration for the Treatment of Pruritus in Patients With Primary Biliary Cholangitis (GLIMMER: GSK2330672 triaL of Ibat Inhibition With Multidose Measurement for Evaluation of Response).

Biliary Cholangitis (GLIMMER: GSK2330672 triaL of Ibat Inhibition With Multidose Measurement for Evaluation of Response).

  • 96 views
  • 25 Mar, 2021
  • 1 location
Linerixibat Long-term Safety, and Tolerability Study (LLSAT)

biliary cholangitis (PBC) who participated in a prior clinical trial with linerixibat (BAT117123 [NCT01899703], 201000 GLIMMER [NCT02966834] (group 1) or 212620 GLISTEN [NCT00210418]) (group 2). All

cholestatic pruritus
cholangitis
  • 39 views
  • 15 Jul, 2022
  • 28 locations
Combination Antiretroviral Therapy (cART) for PBC

Placebo Controlled, double-blind randomized controlled trial (RCT) with 12 months Tenofovir Disoproxil and Raltegravir for primary biliary cholangitis (PBC) patients unresponsive to

  • 16 views
  • 25 Apr, 2022
  • 1 location
Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis (EPICS-III)

Saroglitazar Magnesium 1 mg and 2 mg tablets for treatment of subjects with Primary Biliary Cholangitis (PBC)

  • 0 views
  • 15 May, 2022
  • 1 location
Clinical Research of UCDA Reducing Medication Regimen in Stable PBC (UCDA PBC)

This study explores the feasibility of the reducing medication regimen for Ursodeoxycholic Acid(UDCA) in the treatment of primary biliary cholangitis. The participants will be distributed

  • 4 views
  • 10 May, 2022
  • 1 location
A Phase 2a Double Blind, Placebo Controlled Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-104 in Subjects Ages 18-75 With Primary Biliary Cholangitis Who Are Unresponsive to UDCA and/or OCA

This study is a Phase 2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple ascending doses of CNP-104. The study consists of a 120 day primary study followed by a 20 month long-term safety and durability of response follow-up period.

  • 7 views
  • 25 Oct, 2022
  • 8 locations
Mindfulness - Based Intervention in the Treatment of Fatigue in Patients With Primary Biliary Cholangitis

To assess the efficacy of mindfulness-based intervention (MBI) intervention in the treatment of moderate or severe fatigue in patients with primary biliary cholangitis (PBC).

cholangitis
ursodiol
cirrhosis
fatigue
  • 1 views
  • 07 Oct, 2022
  • 1 location